For instance, the combination of the class I HDAC inhibitor entinostat with the immunocytokine NHS-IL12 effectively restores MHC class I expression and IFN-γ signaling in tumor cells, thereby targeting intrinsic immune resistance. Here, IFNG is linked to neoplasm.